Ft. Lauderdale, Florida (USA) was swarming with eye care professionals from all over the world last month. With close to 6,500 posters and papers in five days and almost 11,000 attendees, there never was a dull moment. Much attention within our interest group was drawn toward ectasia: primary (like keratoconus) and secondary (post-surgery). Corneal crosslinking (CXL) received much attention, as many of the early studies on the topic have now shown their initial results. With many questions still unanswered, it has become clearer that CXL can stabilize the cornea and can even slightly improve the keratometry values, although it seems that the subjective refraction and the wavefront aberrations are typically not much improved. This seems like good news for the ectasia patients, but still no reason to be ecstatic since contact lenses are still needed to restore their vision. This I-site focuses on restoring vision in ectasia with (R)GP lenses, hybrid lenses and scleral lenses. On the latter: scleral lenses were also 'in the news' at ARVO: wavefront aberration correction with scleral lenses (poster#3432), scleral lens fenestrations post-keratoplasty (#3421) and scleral lenses for pain management (#3404) posters were presented by the Boston Foundation for Sight group. But the most exciting news at ARVO was the latest data on  myopia control. Helen Swarbrick presented a poster with the title:  'Overnight Orthokeratology Lens Wear Slows Axial Eye Growth in Myopic Children'. See the special section on orthokeratology in this I-site for more. 

Eef van der Worp